✦ LIBER ✦

Prospective Study of Gefitinib Readministration After Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer Who Previously Responded to Gefitinib

✍ Scribed by Tomonobu Koizumi; Toshihiko Agatsuma; Kayoko Ikegami; Toshiro Suzuki; Takashi Kobayashi; Shintaro Kanda; Sumiko Yoshikawa; Keishi Kubo; Takayuki Shiina; Keiichirou Takasuna; Akemi Matsuo; Muneharu Hayasaka; Miwa Morikawa; Shingo Ameshima

Book ID: 119218675
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 322 KB
Volume: 13
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2012.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of gefitinib re-challenge to init

Effect of gefitinib re-challenge to initial gefitinib responder with non-small cell lung cancer followed by chemotherapy

✍ Tomizawa, Yoshio; Fujita, Yuka; Tamura, Atsuhisa; Shirai, Masahiro; Shibata, Sat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Retreatment of gefitinib in patients wit

Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: A single-arm, open-label, phase II study

✍ Oh, In-Jae; Ban, Hee-Jung; Kim, Kyu-Sik; Kim, Young-Chul 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB

A Randomized Phase II Study of Gefitinib

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

✍ Han, J.-Y.; Lee, S.-H.; Yoo, N. J.; Hyung, L. S.; Moon, Y. J.; Yun, T.; Kim, H. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 317 KB

Randomized phase II study of gefitinib v

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

✍ Kim, Seung Tae; Uhm, Ji Eun; Lee, Jeeyun; Sun, Jong-mu; Sohn, Insuk; Kim, Seon W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Use of Cetuximab After Failure of Gefiti

Use of Cetuximab After Failure of Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer

✍ Jenn-Yu Wu; Chih-Hsin Yang; Ya-Chieh Hsu; Chong-Jen Yu; Shih-Han Chang; Jin-Yuan 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 133 KB

Activity of ZD1839 (Gefitinib, Iressa™)

Activity of ZD1839 (Gefitinib, Iressa™) in Previously Treated Patients with Recurrent and Advanced non—small-Cell Lung Cancer

✍ Angelia D. Gibson; Mark Socinski; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 79 KB